91³Ô¹Ï
+91-22-40012000
companysecretary@marksanspharma.com
91³Ô¹Ï
Company Profile
From the Chairman's Desk
Vision, Core Values
Milestones
Board of Directors
Management Profile
Mergers & Acquisitions
International Operations
Strategy
Subsidiaries
R&D Capabilities
Quality Policy
World Wide Operations
Formulation Business
Overview
Manufacturing Facilities
Markets
Sample Product Portfolio
Health & Wellness
Consumer Self-Care Products
- OTC
Pain Management
Arthritis
Upper Respiratory
Cough & Cold
Allergy
Digestive Health
VMS
(Vitamins Minerals and Supplements)
Vitamins
Skin Care Products
Hair fall
Prescription
– Rx Therapeutic Segments
Cardiovascular System (CVS)
Central Nervous System (CNS)
Oncology
Anti-Diabetics
Anti-Biotic
R&D
Investor
General Information & Investor Contact
General Information
Composition of Board & Committees
Investor Contact
Materiality of Information
Corporate Announcements
Financial Results
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Earnings Call Transcripts
Compliances
Shareholding Pattern
Corporate Governance
Codes & Policies
Independent Directors
Investors Grievance Report
Shareholders Meeting
Unclaimed Dividend
Shares Liable for Transfer to IEPF
Information for Shareholders
CSR Activities
Others Disclosures
Forms
Newspaper Advertisement
Related Party Transaction
Press Release
ESG Profile
Responsibility
CSR
Sustainability
Media
News
Photo / Video Gallery
Adverse Event
Careers
Overview
Values
Life at Marksans
Contact
General Information & Investor Contact
General Information
Composition of Board & Committees
Investor Contact
Materiality of Information
Corporate Announcements
Financial Results
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Earnings Call Transcripts
Compliances
Shareholding Pattern
Corporate Governance
Codes & Policies
Independent Directors
Investors Grievance Report
Shareholders Meeting
Unclaimed Dividend
Shares Liable for Transfer to IEPF
Information for Shareholders
CSR Activities
Others Disclosures
Forms
Newspaper Advertisement
Related Party Transaction
Press Release
ESG Profile
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Earnings Call Transcripts
Investor Relations
Financial Results
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Earnings Call Transcripts
Home
Investor Relations
Financial Results
Investors Presentation
Investors Presentation
2024
2023
2022
2021
2020
2019
2014
2024
Investor Presentation December 2024
Investor Presentation November 2024
Investor Presentation August 2024
Investor Presentation May 2024
Investor Presentation February 2024
2023
Investor Presentation November 2023
Investor Presentation August 2023
Investor Presentation May 2023
Investor Presentation February 2023
2022
Investor Presentation November 2022
Investor Presentation June 2022
Investor Presentation March 2022
2021
Investor Presentation December 2021
Investor Presentation November 2021
Investor Presentation August 2021
Investor Presentation May 2021
2020
Investor Presentation December 2020
Investor Presentation September 2020
Investor Presentation June 2020
Investor Presentation March 2020
2019
Investor Presentation December 2019
Investor Presentation September 2019
Investor Presentation June 2019
2014
Corporate Presentation October 2014
